Clinical Trial Update: Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing voriconazole self nano emulsifying drug delivery system intermediate gel for tinea versicolor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Versicolor

Drugs mentioned

• voriconazole self nano emulsifying drug delivery system intermediate gel (voriconazole)

Snippet

Sponsor: Sara Botros | Conditions: Tinea Versicolor | Phase 2 | Status: COMPLETED